Labiotech.eu

News and Trends 26 Jul 2018

EU Court of Justice Makes Restrictive Ruling on Genome Editing

Genetically-edited organisms that were until now excluded from GMO regulation will now be subject to EU GMO law, which according to experts could harm Europe’s leading position in genome editing. Following a petition from France’s Council of State, the Court of Justice of the EU has stated that mutagenesis techniques should be regulated under GMO […]

July 26, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Agriculture field mulch film biodegradable plastic

More News! 26 Jul 2018

Plastic Type Key to Eco-Friendly Breakdown by Soil Microbes

Swiss research shows that bacteria and fungi in the soil are able to comprehensively break down some types of plastic, but not others. Thin plastic ‘mulch’ films are commonly used by farmers on fields to prevent weeds, but it is often extremely difficult to collect these films after they have been used. “While plastic that […]

July 26, 2018 - 3 minutesmins - By Helen Albert

News and Trends 26 Jul 2018

Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline

The US-UK biotech completed its $100M (€85M) IPO on the NASDAQ stock exchange to further develop ‘oncolytic’ immunotherapies that use the herpes virus to target and attack tumor tissue. Replimune’s immunotherapies use the virus to deliver proteins into tumor tissue that help it fuse with the tumor cells. When the virus fuses to tumor cells, it activates […]

July 26, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 26 Jul 2018

AI Company Raises €8.6M to Find Drugs for Rare Diseases Faster and Cheaper Than Ever

Cambridge-based Healx has raised $10M (€8.6M) in a Series A round to scale up its AI technology, which could significantly reduce the time and cost of developing drugs for rare diseases. Backed, among other investors, by the founder of Abcam, Healx plans to use the fundraising to double its workforce from 15 to over 30 […]

July 26, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

In Depth 25 Jul 2018

Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past?

With the rise of antimicrobial resistance across the globe, and with a dire lack of new antibiotics in the pipeline, more attention is going towards developing innovative treatments and technologies that kill superbugs in completely new ways. Here, we take a closer look at some of the most promising of these technologies emerging from the […]

July 25, 2018 - 5 minutesmins - By Farhan Mitha

News and Trends 25 Jul 2018

Two Drugs as Good as Three for Treating HIV

ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the usual three, which have the potential to reduce the side effects of antiretroviral therapy in the long term. People infected with HIV are treated with lifelong antiretroviral therapy, which traditionally consists of three or more different drugs. The British […]

July 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jul 2018

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Researchers in Vienna are growing mini brains that mimic the onset and development of brain cancer, which could be used to compare the efficacy of different treatments. Because of their cellular complexity, brain cancers have been difficult to study in animals. Glioblastoma, the most aggressive form of brain cancer, is particularly difficult to treat because […]

July 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 24 Jul 2018

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Celyad has received FDA approval to start clinical trials for its CAR-T cell therapy, which is engineered to avoid side effects associated with using donor cells for this kind of treatment. The Belgian biotech has been cleared to test its CAR-T cell therapy, made from donor cells, in patients with unresectable colorectal cancer in combination […]

July 24, 2018 - 2 minutesmins - By Alexander Burik

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us their story, from the drug’s early days to their current role as executives of the biotech unicorn Aduro. Since 2014, the cancer drug Keytruda, also known as pembrolizumab, continues to be widely sought after due […]

July 24, 2018 - 6 minutesmins - By Editorial Team

News and Trends 23 Jul 2018

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15 minutes. Current rapid diagnostic tests for HIV can lead to misdiagnosis, for example when steps in the procedure are not followed in the right order, or too little blood is drawn. The new test, called […]

July 23, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Sangamo Therapeutics has acquired TxCell with a view to utilizing its CAR-T technology to prevent organ transplant rejections and treat autoimmune disease. Sangamo, based in California, is known for bringing the first in-vivo gene therapy to the market. The company entered into an agreement to purchase TxCell for €72M. Sangamo plans to combine its zinc […]

July 23, 2018 - 3 minutesmins - By Alexander Burik

Somewhere in Between Wellcome Collection 1

News and Trends 21 Jul 2018

Somewhere in Between: Exploring Art and Science Collaborations

The latest art and science exhibition at the Wellcome Collection, Somewhere in Between, explores ideas about cattle farming, multisensory synaesthesia, sexual health and virus transmission, and the human capacity to breathe. In an unprecedented level of collaboration, the exhibition is comprised of four art-science projects stemming from projects funded by the Wellcome Trust with the […]

July 21, 2018 - 4 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

EU Court of Justice Makes Restrictive Ruling on Genome Editing

Plastic Type Key to Eco-Friendly Breakdown by Soil Microbes

Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline

AI Company Raises €8.6M to Find Drugs for Rare Diseases Faster and Cheaper Than Ever

Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past?

Two Drugs as Good as Three for Treating HIV

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Somewhere in Between: Exploring Art and Science Collaborations

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!